Detailed Information on Publication Record
2011
Platelet-derived chemokines, PF-4 and RANTES, are significantly increased in hemodynamically significant degenerative aortic stenosis
MOTOVSKA, Z., D. ODVODYOVA, M. KARPISEK, H. HRABAKOVA, V. KOCKA et. al.Basic information
Original name
Platelet-derived chemokines, PF-4 and RANTES, are significantly increased in hemodynamically significant degenerative aortic stenosis
Authors
MOTOVSKA, Z. (703 Slovakia, guarantor), D. ODVODYOVA (203 Czech Republic), M. KARPISEK (203 Czech Republic), H. HRABAKOVA (203 Czech Republic), V. KOCKA (203 Czech Republic), I. SIMKOVA (203 Czech Republic), Stanislav KATINA (703 Slovakia, belonging to the institution) and P. WIDIMSKY (203 Czech Republic)
Edition
International Journal of Cardiology, Ireland, Elsevier, 2011, 0167-5273
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10103 Statistics and probability
Country of publisher
Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 7.078
RIV identification code
RIV/00216224:14310/11:00061085
Organization unit
Faculty of Science
UT WoS
000296540800037
Keywords in English
Degenerative aortic stenosis; Platelet-derived chemokines; Platelet factor-4 (CXCL4); RANTES (CCL5)
Tags
International impact, Reviewed
Změněno: 12/4/2013 10:20, Ing. Andrea Mikešková
Abstract
V originále
Aortic valve stenosis (AoS) is the most common acquired valvular disorder found in developed countries, being present in 2% to 7% of adults over the age of 65 [1], [2] and [3]. Calcified AoS is a chronic progressive disease. The pathomechanisms leading to valve degeneration remain unknown. Valve disease shares many features with atherosclerosis. Platelet activation is an important constituent of the atherosclerotic process [4] and [5]. The study focused on two platelet-derived chemokines, which bridge three important components of atherogenesis: platelet activation, inflammation, and generation of atheroma. The study group was comprised of 124 consecutive patients being considered for aortic valve replacement for symptomatic degenerative trileaflet valvular AoS, and were undergoing cardiac catheterization in the Cardiocentre [6]. The exclusion criterion was the presence of an additional hemodynamically significant valve disease.
Links
CZ.1.07/2.2.00/15.0203, interní kód MU |
|